Avila EK, Tobochnik S, Inati SK, Koekkoek JAF, McKhann GM, Riviello JJ, Rudà R, Schiff D, Tatum WO, Templer JW, Weller M, Wen PY (2024) Brain tumor-related epilepsy management: a Society for Neuro-oncology (SNO) consensus review on current management. Neuro Oncol 26(1):7–24. https://doi.org/10.1093/neuonc/noad154

Article  PubMed  Google Scholar 

Pallud J, Le Van Quyen M, Bielle F, Pellegrino C, Varlet P, Cresto N, Baulac M, Duyckaerts C, Kourdougli N, Chazal G, Devaux B, Rivera C, Miles R, Capelle L, Huberfeld G (2014) Cortical GABAergic excitation contributes to epileptic activities around human glioma. Sci Transl Med. 6(244):244ra89. https://doi.org/10.1126/scitranslmed.3008065

Article  CAS  PubMed  PubMed Central  Google Scholar 

Englot DJ, Chang EF, Vecht CJ (2016) Epilepsy and brain tumors. Handb Clin Neurol 134:267–285. https://doi.org/10.1016/B978-0-12-802997-8.00016-5

Article  PubMed  PubMed Central  Google Scholar 

Lote K, Stenwig AE, Skullerud K, Hirschberg H (1998) Prevalence and prognostic significance of epilepsy in patients with gliomas. Eur J Cancer 34(1):98–102. https://doi.org/10.1016/s0959-8049(97)00374-2

Article  CAS  PubMed  Google Scholar 

Moots PL, Maciunas RJ, Eisert DR, Parker RA, Laporte K, Abou-Khalil B (1995) The course of seizure disorders in patients with malignant gliomas. Arch Neurol 52(7):717–724. https://doi.org/10.1001/archneur.1995.00540310091021

Article  CAS  PubMed  Google Scholar 

Saviuk M, Sleptsova E, Redkin T, Turubanova V (2023) Unexplained causes of glioma-associated epilepsies: a review of theories and an area for research. Cancers (Basel) 15(23):5539. https://doi.org/10.3390/cancers15235539

Article  CAS  PubMed  Google Scholar 

Wu AS, Trinh VT, Suki D, Graham S, Forman A, Weinberg JS, McCutcheon IE, Prabhu SS, Heimberger AB, Sawaya R, Wang X, Qiao W, Hess K, Lang FF (2013) A prospective randomized trial of perioperative seizure prophylaxis in patients with intraparenchymal brain tumors. J Neurosurg 118(4):873–883. https://doi.org/10.3171/2012.12.JNS111970

Article  CAS  PubMed  PubMed Central  Google Scholar 

Weller M, Le Rhun E, Van den Bent M, Chang SM, Cloughesy TF, Goldbrunner R, Hong YK, Jalali R, Jenkinson MD, Minniti G, Nagane M, Razis E, Roth P, Rudà R, Tabatabai G, Wen PY, Short SC, Preusser M (2023) Diagnosis and management of complications from the treatment of primary central nervous system tumors in adults. Neuro Oncol 25(7):1200–1224. https://doi.org/10.1093/neuonc/noad038

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kim YH, Kim T, Joo JD, Han JH, Kim YJ, Kim IA, Yun CH, Kim CY (2015) Survival benefit of levetiracetam in patients treated with concomitant chemoradiotherapy and adjuvant chemotherapy with temozolomide for glioblastoma multiforme. Cancer 121(17):2926–2932. https://doi.org/10.1002/cncr.29439

Article  CAS  PubMed  Google Scholar 

Roh TH, Moon JH, Park HH, Kim EH, Hong CK, Kim SH, Kang SG, Chang JH (2020) Association between survival and levetiracetam use in glioblastoma patients treated with temozolomide chemoradiotherapy. Sci Rep 10(1):10783. https://doi.org/10.1038/s41598-020-67697-w

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cardona AF, Rojas L, Wills B, Bernal L, Ruiz-Patiño A, Arrieta O, Hakim EJ, Hakim F, Mejía JA, Useche N, Bermúdez S, Carranza H, Vargas C, Otero J, Mayor LC, Ortíz LD, Franco S, Ortíz C, Gil-Gil M, Balaña C, Zatarain-Barrón ZL (2018) Efficacy and safety of Levetiracetam vs. other antiepileptic drugs in Hispanic patients with glioblastoma. J Neurooncol. 136(2):363–371. https://doi.org/10.1007/s11060-017-2660-0

Article  CAS  PubMed  Google Scholar 

Ryu JY, Min KL, Chang MJ (2019) Effect of anti-epileptic drugs on the survival of patients with glioblastoma multiforme: a retrospective, single-center study. PLoS One 14(12):e0225599. https://doi.org/10.1371/journal.pone.0225599. (Erratum.In:PLoSOne.2020Feb5;15(2):e0228800 10.1371/journal.pone.0228800)

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bobustuc GC, Baker CH, Limaye A, Jenkins WD, Pearl G, Avgeropoulos NG, Konduri SD (2010) Levetiracetam enhances p53-mediated MGMT inhibition and sensitizes glioblastoma cells to temozolomide. Neuro Oncol 12(9):917–927. https://doi.org/10.1093/neuonc/noq044. (Epub 2010 Jun 4)

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen JS, Clarke R, Haddad AF, Wang EJ, Lacroix M, Sarkar IN, Zand R, Chen ES, Toms SA (2022) The effect of levetiracetam treatment on survival in patients with glioblastoma: a systematic review and meta-analysis. J Neurooncol 156(2):257–267. https://doi.org/10.1007/s11060-021-03940-2

Article  CAS  PubMed  Google Scholar 

Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, Hawkins C, Ng HK, Pfister SM, Reifenberger G, Soffietti R, von Deimling A, Ellison DW (2021) The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol 23(8):1231–1251. https://doi.org/10.1093/neuonc/noab106

Article  CAS  PubMed  PubMed Central  Google Scholar 

Stewart LA, Clarke M, Rovers M, Riley RD, Simmonds M, Stewart G, Tierney JF, PRISMA-IPD Development Group (2015) Preferred reporting items for systematic review and meta-analyses of individual participant data: the PRISMA-IPD statement. JAMA. 313(16):1657–65. https://doi.org/10.1001/jama.2015.3656

Article  PubMed  Google Scholar 

Schardt C, Adams MB, Owens T, Keitz S, Fontelo P (2007) Utilization of the PICO framework to improve searching PubMed for clinical questions. BMC Med Inform Decis Mak 7:16. https://doi.org/10.1186/1472-6947-7-16

Article  PubMed  PubMed Central  Google Scholar 

Ma LL, Wang YY, Yang ZH, Huang D, Weng H, Zeng XT (2020) Methodological quality (risk of bias) assessment tools for primary and secondary medical studies: what are they and which is better? Mil Med Res 7(1):7. https://doi.org/10.1186/s40779-020-00238-8

Article  PubMed  PubMed Central  Google Scholar 

Rakap S, Rakap S, Evran D, Cig O (2016) Comparative evaluation of the reliability and validity of three data extraction programs: UnGraph, GraphClick, and DigitizeIt. Comput Hum Behav 55:159–166. https://doi.org/10.1016/j.chb.2015.09.008

Article  Google Scholar 

Liu N, Zhou Y, Lee JJ (2021) IPDfromKM: reconstruct individual patient data from published Kaplan-Meier survival curves. BMC Med Res Methodol 21(1):111. https://doi.org/10.1186/s12874-021-01308-8

Article  PubMed  PubMed Central  Google Scholar 

Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (eds) (2024) Cochrane handbook for systematic reviews of interventions version 6.4. Cochrane. Available from: www.training.cochrane.org/handbook. Accessed 28 Jan 2024

Bianconi A, Koumantakis E, Gatto A, Zeppa P, Saaid A, Nico E, Bruno F, Pellerino A, Rizzo F, Junemann C, Melcarne A, Garbossa D, Dalmasso P, Cofano F (2023) Effects of Levetiracetam and Lacosamide on survival and seizure control in IDH-wild type glioblastoma during temozolomide plus radiation adjuvant therapy. Brain and Spine 4:102732. https://doi.org/10.1016/j.bas.2023.102732

Article  PubMed  PubMed Central  Google Scholar 

Pallud J, Huberfeld G, Dezamis E, Peeters S, Moiraghi A, Gavaret M, Guinard E, Dhermain F, Varlet P, Oppenheim C, Chrétien F, Roux A, Zanello M (2022) Effect of levetiracetam use duration on overall survival of isocitrate dehydrogenase wild-type glioblastoma in adults: an observational study. Neurology 98(2):e125–e140. https://doi.org/10.1212/WNL.0000000000013005

Article  CAS  PubMed  Google Scholar 

Rigamonti A, Imbesi F, Silvani A, Gaviani P, Agostoni E, Porcu L, De Simone I, Torri V, Salmaggi A (2018) Antiepileptic treatment and survival in newly diagnosed glioblastoma patients: Retrospective multicentre study in 285 Italian patients. J Neurol Sci 390:14–19. https://doi.org/10.1016/j.jns.2018.04.004

Article  CAS  PubMed  Google Scholar 

Jabbarli R, Ahmadipour Y, Rauschenbach L, Santos AN, Darkwah Oppong M, Pierscianek D, Quesada CM, Kebir S, Dammann P, Guberina N, Scheffler B, Kaier K, Stuschke M, Sure U, Wrede KH (2021) How about levetiracetam in Glioblastoma? An institutional experience and meta-analysis. Cancers (Basel) 13(15):3770. https://doi.org/10.3390/cancers13153770

Article  CAS  PubMed  Google Scholar 

Ni XR, Guo CC, Yu YJ, Yu ZH, Cai HP, Wu WC, Ma JX, Chen FR, Wang J, Chen ZP (2020) Combination of levetiracetam and IFN-α increased temozolomide efficacy in MGMT-positive glioma. Cancer Chemother Pharmacol 86(6):773–782. https://doi.org/10.1007/s00280-020-04169-y

Article  CAS  PubMed